Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing StrategyShuo Du, Chuan Qin, Wei Deng et al.|Cell|2020Cited by 288
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2Qi Zhang, Zheng Zhang, Bin Ju et al.|Nature Communications|2021Cited by 146
Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virusYe Sang, Shengqi Wang, Zhen Zhang et al.|Signal Transduction and Targeted Therapy|2023Cited by 107
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYuemei Hu, Ningshao Xia, Zhaofeng Bi et al.|Science Bulletin|2023Cited by 26